Product Detail
Innovation in Drug Research and Development for Prevalent Chronic Diseases
NAP
Pricing & Availability
Available: 0
List Price:$42.95
Other formats:
E E Book + ProQuest Ebook Central
All Formats
Book Information
Edition:
1st
Publisher:
National Academies Press
ISBN:
0-309-09214-0 (0309092140)
ISBN-13:
978-0-309-09214-2 (9780309092142)
Format:
Proceedings MARCH 2021
Binding:
Softcover
Copyright:
2021
Publish Date:
01/22
Weight:
0.43 Lbs.
Pages:
112
Subject Class:
PUB (Public Health)
Return Policy:
Returns accepted up to 90 days provided no other recalls or return restrictions apply.
ProQuest Ebook Central:
Available in ProQuest Ebook Centralâ„¢
View
Class Specifications
Discipline:
Pharmacology
Subject Definition:
Drug Discovery; Chronic Disease
NLM Class:
QV 744
LC Class:
RM301.25
Abstract:
Investment and innovation in drug research and development (R&D) for highly prevalent chronic diseases has stalled in recent decades, despite half of all Americans living with at least one chronic disease. As a result, prevalent chronic diseases are producing immense health care costs as well as preventable suffering and death. On February 22, March 2, and March 8, 2021, the National Academies of Sciences, Engineering, and Medicine, convened a workshop to discuss barriers to innovation in this space and examine strategies and incentives to support equitable, person-centered drug R&D for prevalent chronic diseases.
close
Follow Matthews Book Co. on:
Copyright © 2001-2024 Matthews Book Company - All rights reserved. - 11559 Rock Island Ct., Maryland Heights, MO, 63043 - (800) MED-BOOK
Matthews
Privacy Statement